JP2024516678A5 - - Google Patents

Info

Publication number
JP2024516678A5
JP2024516678A5 JP2023566802A JP2023566802A JP2024516678A5 JP 2024516678 A5 JP2024516678 A5 JP 2024516678A5 JP 2023566802 A JP2023566802 A JP 2023566802A JP 2023566802 A JP2023566802 A JP 2023566802A JP 2024516678 A5 JP2024516678 A5 JP 2024516678A5
Authority
JP
Japan
Prior art keywords
biomarker
amount
hbp
bilirubin
esm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023566802A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024516678A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/061551 external-priority patent/WO2022229421A2/en
Publication of JP2024516678A publication Critical patent/JP2024516678A/ja
Publication of JP2024516678A5 publication Critical patent/JP2024516678A5/ja
Pending legal-status Critical Current

Links

JP2023566802A 2021-04-30 2022-04-29 敗血症の早期検出用のstrem1マーカーパネル Pending JP2024516678A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21171489.4 2021-04-30
EP21171489 2021-04-30
PCT/EP2022/061551 WO2022229421A2 (en) 2021-04-30 2022-04-29 Strem1 marker panels for early detection of sepsis

Publications (2)

Publication Number Publication Date
JP2024516678A JP2024516678A (ja) 2024-04-16
JP2024516678A5 true JP2024516678A5 (https=) 2025-04-24

Family

ID=75746431

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023566802A Pending JP2024516678A (ja) 2021-04-30 2022-04-29 敗血症の早期検出用のstrem1マーカーパネル

Country Status (5)

Country Link
US (1) US20240230674A1 (https=)
EP (1) EP4330680A2 (https=)
JP (1) JP2024516678A (https=)
CN (1) CN117280218A (https=)
WO (1) WO2022229421A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025257393A1 (en) * 2024-06-14 2025-12-18 Roche Diagnostics Gmbh Method and system for improving biomarker based disease assessments

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2476597C (en) 2002-02-28 2011-05-17 Metanomics Gmbh & Co. Kgaa Mass spectrometry method for analysing mixtures of substances
GB0401730D0 (en) * 2004-01-27 2004-03-03 Bioxell Spa Diagnosis method
US20090197794A1 (en) 2005-07-13 2009-08-06 Aird William C Methods of Diagnosing and Treating an Inflammatory Response
AU2006299417A1 (en) * 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in Systemic Inflammatory Response Syndromes
GB0711327D0 (en) * 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
CN103123359B (zh) 2007-08-03 2015-07-29 B.R.A.H.M.S有限公司 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用
ES2506116T3 (es) * 2008-05-23 2014-10-13 Biocartis Nv Nuevo biomarcador para diagnóstico, predicción y/o pronóstico de septicemia y usos del mismo
US20110287433A1 (en) * 2008-10-28 2011-11-24 Didier Payen De La Garanderie Methods and Kits for the Rapid Determination of Patients at High Risk of Death During Severe Sepsis and Septic Shock
JP2012159356A (ja) * 2011-01-31 2012-08-23 Mochida Pharmaceut Co Ltd 敗血症診断用組合せマーカー
CN108802385B (zh) * 2012-02-09 2022-02-08 米密德诊断学有限公司 用于诊断感染的标记和决定因素和其使用方法
RU2016112915A (ru) 2013-09-05 2017-10-09 Эф-Ай-Оу Корпорейшн Биомаркеры для раннего выявления критической или угрожающей жизни ответной реакции на заболевание и/или ответной реакции на лечение

Similar Documents

Publication Publication Date Title
Lau et al. Early detection of pulmonary arterial hypertension
JP6595984B2 (ja) 腎機能に関連付けられるバイオマーカーおよびそれを使用する方法
JP5759372B2 (ja) 糖尿病性腎症の検査方法
Fung et al. A biomarker panel for peripheral arterial disease
US20130210667A1 (en) Biomarkers for Predicting Kidney and Glomerular Pathologies
JP2023134563A (ja) 歯周炎の診断方法、使用及びキット
Makaryus et al. Falsely elevated cardiac troponin I levels
Terlecki et al. Prognostic value of acid-base balance parameters assessed on admission in peripheral venous blood of patients with myocardial infarction treated with percutaneous coronary intervention
Kavsak et al. The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations
JP2024516678A5 (https=)
JP2024516680A5 (https=)
JP2024516677A5 (https=)
WO2003039349A2 (en) Method of using physiological markers to estimate cardiovascular risk
JP2024515086A5 (https=)
CN115586342B (zh) 血清可溶性st2在制备预测主动脉夹层患者预后产品中的应用及相关预测装置
JP2024516001A5 (https=)
JP2024516681A5 (https=)
CN111065922A (zh) 肾上腺髓质素原作为危重病患者的肾脏替代治疗的指标
JP2024516679A5 (https=)
WO2024154832A1 (ja) 全身性強皮症の検出方法
JP2024537774A5 (https=)
JP6727660B2 (ja) 糖尿病性腎症の判定マーカー
JP6220222B2 (ja) 関節リウマチの診断を補助するための方法、システム及びコンピュータプログラム製品
JP2024516665A5 (https=)
JP5339227B2 (ja) アクロレイン、インターロイキン−6及びcrpの含有量、ポリアミンオキシダーゼ活性又はポリアミンオキシダーゼの蛋白質量、並びに、被験者の年齢を指標とした脳卒中・無症候性脳梗塞の検出方法